Tardive Syndromes: Clinical Manifestations and Management

Definition and Etiology

• The American Academy of Child and Adolescent Psychiatry notes that tardive dystonia is characterized by slow movements along the body's long axis culminating in spasms, and may include facial spasms 1

Risk Factors

• Up to 50% of youth receiving neuroleptics may experience some form of tardive or withdrawal dyskinesia 2

Prevention and Monitoring

• Prevention is critical as treatment options are limited once tardive syndromes develop 2
• Use atypical antipsychotics when possible, as they have lower TD risk compared to typical antipsychotics 2
• Baseline assessment of abnormal movements should be recorded before starting antipsychotic therapy 2
• Regular monitoring using standardized measures like the Abnormal Involuntary Movement Scale (AIMS) should occur every 3-6 months 2
• Early detection is crucial as tardive syndromes may persist even after medication discontinuation 2

Management Approaches

• If clinically feasible, gradually withdraw the offending antipsychotic medication 2
• Consider switching to atypical antipsychotics with lower D2 affinity 2
• The concern over tardive syndromes should not outweigh potential benefits of antipsychotics for patients who genuinely need these medications 2